ANDREWS DEBORAH J 4
4 · STAAR SURGICAL CO · Filed Mar 16, 2026
Research Summary
AI-generated summary of this filing
STAAR SURGICAL (STAA) Interim Co-CEO Deborah Andrews Receives Award
What Happened
- Deborah J. Andrews, Interim Co-CEO and CFO of STAAR Surgical (STAA), was granted 39,809 restricted stock units (RSUs) on March 13, 2026. The award was granted with no cash consideration (reported price $0.00) and is a derivative grant (RSUs).
Key Details
- Transaction date: March 13, 2026; Form 4 filed March 16, 2026 (appears timely).
- Grant: 39,809 RSUs (each RSU converts to one share upon vesting).
- Vesting: 1/3 vests on March 13, 2027 (13,269 RSUs), 1/3 on March 13, 2028 (13,270 RSUs), and 1/3 on March 13, 2029 (13,270 RSUs).
- Consideration: $0.00 at grant (standard for RSU awards).
- Shares owned after transaction: not specified in the provided excerpt.
- Footnotes: award described as annual equity award; RSUs represent the right to receive common stock on vesting.
Context
- RSU grants are common executive compensation and do not represent immediate stock ownership until vesting; they are not a purchase or sale and do not necessarily indicate a near-term trading signal. This was an award/compensation grant rather than an open-market buy or sale.
Insider Transaction Report
Form 4
ANDREWS DEBORAH J
Interim Co-CEO and CFO
Transactions
- Award
Restricted Stock Units
[F1][F2]2026-03-13+39,809→ 39,809 totalExercise: $0.00→ Common Stock (39,809 underlying)
Footnotes (2)
- [F1]Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.
- [F2]Reflects RSUs granted to the Reporting Person on March 13, 2026 in connection with annual equity award. These RSUs vest as to 1/3 (13,269 shares) on March 13, 2027, 1/3 (13,270 shares) on March 13, 2028, and 1/3 (13,270 shares) on March 13, 2029.
Signature
/s/ Deborah Andrews|2026-03-13